CAPSULE FORMULATIONS
    5.
    发明公开

    公开(公告)号:US20240299306A1

    公开(公告)日:2024-09-12

    申请号:US18437368

    申请日:2024-02-09

    IPC分类号: A61K9/48 A61K31/4412

    摘要: The present disclosure provides solid solution capsule formulations of Compound 1




    and methods of making the same. Also provided herein are methods of treating individuals suffering from or susceptible to a disease or disorder involving pathologic activation of C5a receptors by administering an effective amount of one or more solid solution capsules comprising Compound 1. Further provided herein are singe unit dosage capsules comprising certain amounts of Compound 1, and kits comprising a solid solution capsule comprising Compound 1.